OMJJARA cpr pell 150 mg bte 30 pce

7680694280020 CH-69428 L01EJ04 07.16.1.

Reimbursement limitations:

OMJJARA

Le remboursement nécessite une garantie de prise en charge par l’assurance maladie, après consultation préalable …

OMJJARA cpr pell 150 mg bte 30 pce
OMJJARA cpr pell 150 mg bte 30 pce
OMJJARA cpr pell 150 mg bte 30 pce
1 / 3
google

Details

Product number
6942802
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
momelotinibum 150 mg ut momelotinibi dihydrochloridum monohydricum, cellulosum microcristallinum, lactosum monohydricum 76.14 mg, carboxymethylamylum natricum A, magnesii stearas, silica colloidalis anhydrica, E 310, Überzug: poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.13 mg.

Articles (1)

Omjjara 150 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Professional SmPC
Allemand
27/06/2025
Professional SmPC
Français
27/06/2025
Professional SmPC
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
76.14 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 4376.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2025

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
69428
Drug name
Omjjara, Filmtabletten
Galenic form
FILM
ATC Code
L01EJ04
Authorization status
Z
Dispensation category
A
First authorization
25/09/2024
Authorization expiration date
24/09/2029
IT number
07.16.1.
Domain
Human medicine
Field of application
Primäre Myelofibrose, Myelofibrose nach Polycythaemia vera oder Myelofibrose nach essentieller Thrombozythämie

Packaging details

Description (FR)
OMJJARA cpr pell 150 mg bte 30 pce
Description (DE)
OMJJARA Filmtabl 150 mg Ds 30 Stk
Market launch
25/09/2024
Narcotic (BTM)
No

Other packaging sizes

OMJJARA cpr pell 100 mg bte 30 pce
30 TABL
View
OMJJARA cpr pell 200 mg bte 30 pce
30 TABL
View